Yes, the GBM testing of PD1 is actually why I like the combo idea and agree it should transfer well to Direct. They need help combating immunosuppression. I posted that exact patent pursuit last summer. See the GBM example within the patent that exactly matches my post in December 2014. Thank you for trying to post something new. :)
The findings from the Phase I trial also open the door for potential combination therapy of DCVax-Direct with checkpoint inhibitors. -- Highwayman quoting NWBT
You can open a door wide, but it doesn't mean anyone will come inside. :)